We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
(+0.28%)
Cap. Flow
-$3.21B
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$285M |
| 2 |
Applied Materials
AMAT
|
+$234M |
| 3 |
Micron Technology
MU
|
+$185M |
| 4 |
Merck
MRK
|
+$161M |
| 5 |
NXP Semiconductors
NXPI
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$505M |
| 2 |
Bank of America
BAC
|
+$339M |
| 3 |
Nike
NKE
|
+$335M |
| 4 |
Union Pacific
UNP
|
+$329M |
| 5 |
Citigroup
C
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Financials | 16.82% |
| 3 | Consumer Discretionary | 16.55% |
| 4 | Healthcare | 14.39% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Liquidity Services
LQDT
$1.32B
| $1.27M | ﹤0.01% |
212,603
-12,300
| -5% | -$79.1K |
|
|
ACBI
1277
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $1.26M | ﹤0.01% |
68,953
+46,853
| +212% | +$860K |
|
1278
Mercer International
MERC
$39.8M
| $1.26M | ﹤0.01% |
+102,682
| New | +$1.25M |
|
|
INWK
1279
DELISTED
InnerWorkings, Inc.
INWK
| $1.26M | ﹤0.01% |
228,851
-16,521
| -7% | -$80.1K |
|
1280
Commercial Vehicle Group
CVGI
$147M
| $1.26M | ﹤0.01% |
198,184
+85,451
| +76% | +$607K |
|
|
SNR
1281
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $1.25M | ﹤0.01% |
+163,245
| New | +$1.21M |
|
1282
Graphic Packaging
GPK
$3.58B
| $1.24M | ﹤0.01% |
74,655
+49,355
| +195% | +$782K |
|
1283
PG&E
PCG
$38.5B
| $1.24M | ﹤0.01% |
114,200
-442,435
| -79% | -$3.79M |
|
|
IMGN
1284
DELISTED
Immunogen Inc
IMGN
| $1.24M | ﹤0.01% |
+243,150
| New | +$825K |
|
|
SSI
1285
DELISTED
Stage Stores Inc
SSI
| $1.24M | ﹤0.01% |
+152,411
| New | +$591K |
|
1286
Supernus Pharmaceuticals
SUPN
$2.77B
| $1.23M | ﹤0.01% |
+51,781
| New | +$1.26M |
|
1287
Sempra
SRE
$54.8B
| $1.23M | ﹤0.01% |
+16,200
| New | +$1.19M |
|
1288
Silicon Laboratories
SLAB
$7.23B
| $1.21M | ﹤0.01% |
10,388
-1,400
| -12% | -$154K |
|
1289
UFP Technologies
UFPT
$2.43B
| $1.2M | ﹤0.01% |
24,213
-3,400
| -12% | -$148K |
|
1290
Teekay
TK
$985M
| $1.2M | ﹤0.01% |
+225,301
| New | +$1.11M |
|
1291
IDT Corp
IDT
$1.62B
| $1.19M | ﹤0.01% |
165,535
-2,500
| -1% | -$18K |
|
1292
Navios Maritime Partners
NMM
$2.26B
| $1.18M | ﹤0.01% |
63,609
-2,583
| -4% | -$48.2K |
|
1293
United Natural Foods
UNFI
$2.85B
| $1.18M | ﹤0.01% |
+135,200
| New | +$1.09M |
|
1294
Innovative Industrial Properties
IIPR
$1.72B
| $1.18M | ﹤0.01% |
15,567
-2,197
| -12% | -$170K |
|
1295
Cheesecake Factory
CAKE
$5.33B
| $1.17M | ﹤0.01% |
30,200
-648,399
| -96% | -$26.7M |
|
|
GPX
1296
DELISTED
GP Strategies Corp.
GPX
| $1.17M | ﹤0.01% |
88,356
| – | – |
|
|
TVRD
1297
Tvardi Therapeutics
TVRD
$23.4M
| $1.16M | ﹤0.01% |
+2,006
| New | +$1.41M |
|
1298
Dorchester Minerals
DMLP
$1.26B
| $1.16M | ﹤0.01% |
59,524
-67,855
| -53% | -$1.22M |
|
1299
Riverview Bancorp
RVSB
$108M
| $1.15M | ﹤0.01% |
139,646
+21,618
| +18% | +$162K |
|
1300
Bassett Furniture
BSET
$176M
| $1.14M | ﹤0.01% |
68,141
| – | – |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.
- Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
- Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
- Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
- Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
- Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
- Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.
Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.